HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,730 | -66.6% | 150 | -68.5% | 0.00% | – |
| Q2 2023 | $17,169 | +199.7% | 476 | +217.3% | 0.00% | – |
| Q1 2023 | $5,729 | -65.4% | 150 | -48.5% | 0.00% | – |
| Q4 2022 | $16,558 | +176.0% | 291 | +94.0% | 0.00% | – |
| Q3 2022 | $6,000 | -14.3% | 150 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | +16.7% | 150 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -62.5% | 150 | -63.1% | 0.00% | – |
| Q3 2021 | $16,000 | +700.0% | 407 | +892.7% | 0.00% | – |
| Q4 2020 | $2,000 | -92.6% | 41 | -97.6% | 0.00% | – |
| Q3 2019 | $27,000 | +2600.0% | 1,734 | +5000.0% | 0.00% | – |
| Q2 2019 | $1,000 | -95.0% | 34 | -96.6% | 0.00% | – |
| Q1 2018 | $20,000 | +1900.0% | 1,000 | +1512.9% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 62 | -59.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 154 | +516.0% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 25 | -91.7% | 0.00% | – |
| Q2 2013 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |